352 related articles for article (PubMed ID: 28481729)
41. Novel anticonvulsant drugs.
Stefan H; Feuerstein TJ
Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
[TBL] [Abstract][Full Text] [Related]
42. [Rational combinations of antiepileptic drugs for refractory epilepsy].
Yoshino A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Apr; 31(2):65-72. PubMed ID: 21626890
[TBL] [Abstract][Full Text] [Related]
43. Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Sawicka KM; Załuska K; Wawryniuk A; Załuska-Patel K; Szczyrek M; Drop B; Daniluk J; Szpringer M; Żółkowska D; Łuszczki JJ
Epilepsy Res; 2017 Jul; 133():67-70. PubMed ID: 28458102
[TBL] [Abstract][Full Text] [Related]
44. Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study.
El-Farahaty RM; El-Mitwalli A; Azzam H; Wasel Y; Elrakhawy MM; Hasaneen BM
J Child Neurol; 2015 Mar; 30(4):451-7. PubMed ID: 25342306
[TBL] [Abstract][Full Text] [Related]
45. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
46. Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
Meador KJ; Yang H; Piña-Garza JE; Laurenza A; Kumar D; Wesnes KA
Epilepsia; 2016 Feb; 57(2):243-51. PubMed ID: 26724782
[TBL] [Abstract][Full Text] [Related]
47. Preliminary open-label experience with topiramate in primary generalized seizures.
Biton V
Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
[TBL] [Abstract][Full Text] [Related]
48. Disabling tremor after lamotrigine with sodium valproate.
Reutens DC; Duncan JS; Patsalos PN
Lancet; 1993 Jul; 342(8864):185-6. PubMed ID: 8101290
[No Abstract] [Full Text] [Related]
49. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
[TBL] [Abstract][Full Text] [Related]
50. Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Rosati A; Ilvento L; Lucenteforte E; Pugi A; Crescioli G; McGreevy KS; Virgili G; Mugelli A; De Masi S; Guerrini R
Epilepsia; 2018 Feb; 59(2):297-314. PubMed ID: 29270989
[TBL] [Abstract][Full Text] [Related]
51. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
Thibert RL; Conant KD; Braun EK; Bruno P; Said RR; Nespeca MP; Thiele EA
Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717
[TBL] [Abstract][Full Text] [Related]
52. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
[TBL] [Abstract][Full Text] [Related]
53. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
[TBL] [Abstract][Full Text] [Related]
54. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
55. Practical management issues for idiopathic generalized epilepsies.
Benbadis SR
Epilepsia; 2005; 46 Suppl 9():125-32. PubMed ID: 16302886
[TBL] [Abstract][Full Text] [Related]
56. Levetiracetam in the treatment of idiopathic generalized epilepsies.
Grünewald R
Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
[TBL] [Abstract][Full Text] [Related]
57. Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures.
Trinka E; Lattanzi S; Carpenter K; Corradetti T; Nucera B; Rinaldi F; Shankar R; Brigo F
CNS Drugs; 2021 Aug; 35(8):821-837. PubMed ID: 34232492
[TBL] [Abstract][Full Text] [Related]
58. [Clinical efficacy and tolerability of topamax in combined therapy of epilepsy].
Mukhin KIu; Petrukhin AS; Mironov MB
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(3):28-33. PubMed ID: 12830503
[TBL] [Abstract][Full Text] [Related]
59. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
60. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
